Possible Different Mechanism between Amyloid-Beta (25–35)- and Substance P-lnduced Chemotaxis of Murine Microglia

Gerontology

Volumn 43, Issue , 1997, Pages 11-15

  Maeda, Kiyoshi ^a   Nakai, Masamichi ^a   Maeda, Sakan ^b   Kawamata, Toshio ^a   Yamaguchi, Tooru ^a   Tanaka, Chikako ^a  

^a Institute for Aging Brain and Cognitive Disorders   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyloid protein (25 35); Desensitization; Microglia; Substance P

Indexed keywords

AMYLOID BETA PROTEIN; NEUROKININ 1 RECEPTOR; NEUROKININ A [3-10][3 LYSINE 8 GLYCINE GAMMA LACTAM 9 LEUCINE]; SENKTIDE; SUBSTANCE P;

ANIMAL CELL; CHEMOTAXIS; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DESENSITIZATION; EMBRYO; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELLS, CULTURED; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; MICROGLIA; NEUROFIBRILLARY TANGLES; NEUROKININ A; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; SUBSTANCE P;

EID: 0030982047     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213881     Document Type: Article

References (19)

1. Glenner GG, Wong CG: Alzheimer’s disease: Initial report on the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys Res Comrnun 1984;120:885-890.
2. Yankner BA, Mesulam M-M: 15-Amyloid and the pathogenesis of Alzheimer’s disease, N Engl J Med 1991;325:1849-1857.
3. Selkoe DL: Alzheimer’s disease: A central role for amyloid: J Ncuropa-thol Exp Neurol 1994;53:438-447.
4. Yankner BA, Duffy LK, Kirschncr DA: Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides, Science 1990;250:279-282.
5. Loo DT, Copani A, Pike CJ, Whitte-rnore ER, Walencewicz AJ, Cotman CW: Apoptosis is induced by β-amyloid in cultured central nervous system neurons, Proc Natl Acad Sci USA 1993;90:7951-7955.
6. Busciglio J, Lorenzo A, Yeh J, Yankner BA: β-Amyloid fibrils induce tau phosphorylation and loss of microtubulc binding, Neuron 1995; 14:879-888.
7. LaFerla FM, Tinkle BT, Bicberich CJ, Haudenschild CC, Jay G: The Alzheimer’s A-β peptide induces neurodcgcncration and apoptotic cell death in transgenic mice, Nature Genet 1995:9:21-30.
8. Uchihara T, Duyckacrts C, He Y, Kobayashi K, Seilhean D, Amoucl P, Hauw JJ: Apo E immunoreactivi-ty and microglial cells in Alzheimer’s disease brain, Neurosci Lett 1995;195:5-8.
9. Wisniewski HM, Barcikowska M, Kida E: Phagocytosis of β/A4 amyloid fibrils of the neuritic neocortical plaques, Acta Neuropathol 1991:81: 588-590.
10. Meda L, Cassatella MA, Szendrei GI, Otovos L-Jr, Baron P, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by β-amyloid protein and interferon-y, Nature 1995; 374:647-650.
11. London JA, Biegel D, Pachtcr JP: Neurocytopathic effects of p-amy-loid-stimulated monocytes: A potential mechanism for central nervous system damage in Alzheimer disease, Proc Natl Acad Sci USA 1996; 93:4147-4152.
12. Davis JB, McMurray HF, Schubert D: The amyloid β-protein of Alzheimer’s disease is chemotactic for mononuclear phagocytes, Biochem Biophys Res Comrnun 1992:189: 1096-1100.
13. Duncan DB: The multiple range and multiple F tests, Biometrics 1995; 11:1-42.
14. Thomas WE: Brain macrophages: Evaluation of microglia and their functions, Brain Res 1992; 17:61-74.
15. Seubert P, Vigo-Pclfrcy C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Scholssmacher M, Whaley J, Swin-dlehurst C, McCormack R, Wolfert R, Selkoe D: Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids, Nature 1992;359:325-327.
16. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA: An in vivo model for the neurodegenerative effects of p amyloid and protection by substance P, Proc Natl Acad Sci USA 1991;88:7247-7251.
17. Chauhan A, Chauhan VP, Brocker-hoff H, Wisniewski HM: Action of amyloid b-protein on protein kinase C activity, Life Sci 1991;49:1555-1562.
18. Hogan MV, Pawlowska Z, Yang HA, Kornccki E, Ehrlich YH: Surface phosphorylation by ecto-pro-tein kinase C in brain neurons: A target for Alzheimer’s p-amyloid peptides, J Neurochem 1995;65: 2022-2030.
19. Luo YQ, Hirashima N, Li YH, Al-kon DL, Sunderland T, Etchcberri-garay R, Wolozin B: Physiological levels of p-amyloid increase tyrosine phosphorylation and cytosolic calcium, Brain Res 1995;681:65-74.